Oxford-based OrganOx has been sold in a mammoth £1.1bn deal. The company’s pioneering liver perfusion technology has transformed outcomes for transplant patients worldwide. One of UK’s largest MedTech exits to date, it marks investor BGF’s largest ever return, generating £175m of proceeds – a 10x multiple exit on its initial investment. BGF first invested in … Continue reading MedTech OrganOx sold in £1.1bn deal